GlycoNex Incorporation (TPEX:4168)
Taiwan · Delayed Price · Currency is TWD 26.20
0.00 (0.00%)
Jun 3, 2026, 1:30 PM CST
GlycoNex Incorporation Market Cap
GlycoNex Incorporation has a market cap or net worth of 2.95 billion as of June 3, 2026. Its market cap has increased by 52.63% in one year.
Market Cap
2.95B
Enterprise Value
2.81B
Revenue
36.35M
Ranking
n/a
PE Ratio
n/a
Stock Price
26.20
Market Cap Chart
Since December 16, 2011, GlycoNex Incorporation's market cap has increased from 1.51B to 2.95B, an increase of 95.56%. That is a compound annual growth rate of 4.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 3, 2026 | 2.95B | 5.80% |
| Dec 31, 2025 | 2.79B | 2.79% |
| Dec 31, 2024 | 2.71B | -16.13% |
| Dec 29, 2023 | 3.23B | -0.89% |
| Dec 30, 2022 | 3.26B | 13.02% |
| Dec 30, 2021 | 2.89B | 3.11% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BioGend Therapeutics | 3.23B |
| SYN-TECH Chem. & Pharm. | 3.20B |
| Shine-On BioMedical | 3.20B |
| Genovate Biotechnology | 3.03B |
| Chunghwa Chemical Synthesis & Biotech | 3.00B |
| Apex Biotechnology | 2.99B |
| HeXun Biosciences | 2.93B |
| TWi Biotechnology | 2.92B |